Thymosin Alpha-1 – 10mg

Thymosin Alpha 1 (T-alpha-1) is a naturally occurring 28-amino acid peptide originally isolated from thymic tissue and characterized as a key regulator of immune cell maturation and function. In laboratory research, Thymosin Alpha 1 has been extensively studied for its immunomodulatory properties, with published investigations documenting its effects on dendritic cell maturation, T-lymphocyte differentiation, natural killer cell activation, and toll-like receptor signaling pathways across diverse immune cell populations and experimental model systems.

The peptide acts primarily through TLR9 and TLR2 agonism, initiating MyD88-dependent signaling cascades that culminate in the activation of NF-kB and IRF-7 transcription factors and the subsequent induction of type I interferon and pro-inflammatory cytokine expression. In vitro studies using peripheral blood mononuclear cell (PBMC) preparations and purified immune cell subsets have demonstrated that Thymosin Alpha 1 promotes phenotypic maturation of dendritic cells, enhances antigen presentation capacity, and modulates the Th1/Th2 cytokine balance in a concentration-dependent manner. Researchers studying adaptive immunity, vaccine adjuvant biology, and immunosenescence mechanisms have found Thymosin Alpha 1 to be a valuable experimental reagent.